Description: NIOX Group Plc engages in the design, development, and commercialization of medical devices for the measurement of fractional exhaled nitric oxide (FeNo) worldwide. Its products include NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device and a range of consumables, including sensors, individual disposable mouthpieces, and breathing handles for the measurement of FeNo level in patients. The company was formerly known as Circassia Group Plc and changed its name to NIOX Group Plc in September 2022. NIOX Group Plc was incorporated in 2006 and is headquartered in Oxford, the United Kingdom.
Home Page: investors.niox.com
Hayakawa Building
Oxford,
OX4 4GB
United Kingdom
Phone:
44 3303 309 356
Officers
| Name | Title |
|---|---|
| Mr. Ian Roy Johnson | Executive Chairman |
| Mr. Michael Roy David Roller A.C.A., BA (Hons) | CFO & Director |
| Mr. Jonathan Emms | COO & Executive Director |
| Ms. Nina Kataria | Senior Vice President Global Human Resources |
| Mr. Tom Scaccia | Senior Vice President of Americas & Research Business |
| Ms. Sarah Elizabeth Duncan | Company Secretary |
Exchange: OTCGREY
Country: US : United States of America
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 21.6667 |
| Price-to-Book MRQ: | 2.908 |
| Price-to-Sales TTM: | 8.5497 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 92 |